ArticleActa parasitologica2025
Changing Trends in the Cysticercosis-Related Disease Burden from 1990 to 2021 and its Predicted Level in 2022-2050 Years.
Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- First analysis of Spirometra mansoni excretory-secretory proteins by the 4D-DIA method.Parasite (Paris, France) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundA major worldwide health concern is cysticercosis, a zoonotic parasitic illness brought on by human parasites. This study aims to examine the current worldwide cysticercosis burden in order to serve as a resource for developing successful global control initiatives.
methodsFive layers of data about cysticercosis were analyzed: gender, age, year, and the regional and national social and economic development index (SDI). The various groups were compared using age-standardized rates, and patterns in the burden of disease were examined and evaluated. Furthermore, from 2022 to 2050, disease patterns were predicted using the ARIMA and ES models.
resultsIt was discovered that compared with 1990, the number of deaths decreased by 362 in 2021, the prevalence number increased by 1,318,963, the DALYs decreased by 151,192, and the age-standardized Mortality rate (ASMR) decreased by 0.02 per 100,000 people (EAPC - 2.39, 95% CI - 2.46 to - 2.32), the age-standardized DALY rate (ASDR) decreased by 9.14 per 100,000 people (EAPC - 1.84, 95% CI - 1.93 to - 1.75), and the age-standardized prevalence rate (ASPR) decreased by 17.18 per 100,000 people (EAPC - 1.2, 95% CI - 1.3 to - 1.1).
conclusionsTo sum up, although the prevalence of cysticercosis has dramatically declined globally over the last 30 years, it is still high in many low-SDI nations and regions. Therefore, in order to further optimize prevention and control methods and lower the burden of disease in high-burden regions and countries, it is imperative that international cooperation be strengthened.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.